Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factor.
about
Cysteamine enhances the procoagulant activity of Factor VIII-East Hartford, a dysfunctional protein due to a light chain thrombin cleavage site mutation (arginine-1689 to cysteine)Aggregation of human platelets by commercial preparations of bovine and porcine antihaemophilic globulin.Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372----histidine).The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, anThe immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8.Synthesis of antihemophilic factor antigen by cultured human endothelial cellsMesterolone: thrombosis during treatment, and a study of its prothrombotic effects.Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid.Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.The effects of epinephrine infusion in patients with von Willebrand's disease.Factor VIII-East Hartford (arginine 1689 to cysteine) has procoagulant activity when separated from von Willebrand factor.[THE PROPORTION OF ANTIHEMOPHILIC FACTORS: BIOLOGICAL AND GENETIC CORRELATION WAS DETERMINED ON 55 SUBJECTS].Immunoinhibition of ristocetin-induced platelet aggregation.A CIRCULATING ANTICOAGULANT INHIBITING ANTIHAEMOPHILIC GLOBULINEffect of intravenous prostaglandin E 2 on platelet function, coagulation, and fibrinolysisCoagulation studies in rheumatic heart disease.Hemophilia A due to mutations that create new N-glycosylation sites.Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes.The properties of immune complexes formed by human antibodies to factor VIII.Synthesis of von Willebrand factor by cultured human endothelial cells.Synthesis of clotting factors by the isolated perfused rat liver.Hereditary deficiency of the sixth component of complement in man. II. Studies of hemostasis.Serum enzyme changes after intramuscular bleeding in patients with haemophilia and Christmas diseaseINCREASED VASCULAR PERMEABILITY INDUCED BY HUMAN PLASMIN.Subcellular platelet factor VIII antigen and von Willebrand factor.Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review.Preoperative prediction of postoperative deep vein thrombosis.Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease.Haemostatic mechanism in the uterine circulation during placental separation.
P2860
Q28319571-31C025FF-817E-4DAD-A779-0A0EF713DB54Q33468415-E5098420-4B1B-4E69-9667-0C880D1EB81EQ33868116-DD4B23E9-5528-4DFF-BF07-858958B79B28Q34076628-CAC4E2AB-D706-4819-8EFC-66B318EFB6EFQ34266673-E58B5EA1-1437-44C9-9287-28BBCA633190Q34513117-F8BC189D-695F-41BD-8155-6C888A696764Q34517370-07A7322D-86F3-49BB-8BEA-27D55557368FQ34575122-20D11575-9A64-400D-81B5-E9211EF68ACFQ34713044-F1246A91-16FD-4754-B07D-5199BB4BADA0Q35202071-D641ED23-1F22-4D96-9915-D1F5E8D4B3A3Q35601547-7EAD9E87-9FCB-4471-B79E-546D63F11F51Q35904934-6EA63BF8-E1DF-4C34-A5E3-CDAC51B4ED1EQ35905523-F9D355BB-253B-459F-B2F3-9D882F13CDFCQ36509504-38D52BC9-E785-4CC0-8167-B642ED227950Q36649123-DA08B7CA-56B3-46C5-8B9C-69C40F0A927CQ36771297-BE368B72-56B7-45E8-A2BB-62B17EB79D3DQ37036321-C33A4DBE-BD2E-4900-8ADA-B2E492F68AAEQ37047673-C91FCB24-A2C5-451B-8CD2-F7092A7FAF3EQ37048262-B656B5DE-7EE9-4FEA-8AE9-43866C4CF422Q37444356-4B9E3C7C-C2B8-4F96-A54B-B8C742E7179BQ40328329-72613B7A-E496-4726-85F8-71EA3152EBBEQ40368016-E7BC22E2-1216-4D2A-98E2-F2C8E6103C1BQ41260015-9DEC8A3B-8A4D-4D8E-9A1C-CA1B4A96AD12Q41936740-69B51EFD-8B9D-4C19-AE7C-03AA0032CB39Q42940232-A7E8C50B-6843-4802-A57C-0848EA969D4BQ49988033-CB32737C-7B22-4E13-BDE5-A52F51A395EDQ52438339-FC10F240-0F09-49C7-B886-0F8972794B19Q55061492-62B0342E-920C-4D88-B689-351A94738E0AQ55128834-74FB9332-DC19-4334-956B-816176BB34DF
P2860
Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factor.
description
1962 nî lūn-bûn
@nan
1962年の論文
@ja
1962年学术文章
@wuu
1962年学术文章
@zh
1962年学术文章
@zh-cn
1962年学术文章
@zh-hans
1962年学术文章
@zh-my
1962年学术文章
@zh-sg
1962年學術文章
@yue
1962年學術文章
@zh-hant
name
Studies on the nature of the c ...... ssay for anthemophilic factor.
@en
Studies on the nature of the c ...... ssay for anthemophilic factor.
@nl
type
label
Studies on the nature of the c ...... ssay for anthemophilic factor.
@en
Studies on the nature of the c ...... ssay for anthemophilic factor.
@nl
prefLabel
Studies on the nature of the c ...... ssay for anthemophilic factor.
@en
Studies on the nature of the c ...... ssay for anthemophilic factor.
@nl
P1433
P1476
Studies on the nature of the c ...... ssay for anthemophilic factor.
@en
P2093
BRECKENRIDGE RT
RATNOFF CD
P304
P407
P577
1962-08-01T00:00:00Z